112 related articles for article (PubMed ID: 36989865)
1. Role and regulation of GLUT1/3 during oral cancer progression and therapy resistance.
Kumari A; Jha A; Tiwari A; Nath N; Kumar A; Nagini S; Mishra R
Arch Oral Biol; 2023 Jun; 150():105688. PubMed ID: 36989865
[TBL] [Abstract][Full Text] [Related]
2. Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer.
Alam M; Mishra R
Life Sci; 2021 Sep; 280():119705. PubMed ID: 34111459
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
4. The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance.
Alam M; Kashyap T; Pramanik KK; Singh AK; Nagini S; Mishra R
Clin Oral Investig; 2017 Dec; 21(9):2721-2731. PubMed ID: 28233171
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance.
Jha A; Alam M; Kashyap T; Nath N; Kumari A; Pramanik KK; Nagini S; Mishra R
Int Immunopharmacol; 2023 Nov; 124(Pt A):110894. PubMed ID: 37678027
[TBL] [Abstract][Full Text] [Related]
6. Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance.
Alam M; Kashyap T; Mishra P; Panda AK; Nagini S; Mishra R
Head Neck; 2019 Jan; 41(1):185-197. PubMed ID: 30549344
[TBL] [Abstract][Full Text] [Related]
7. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC).
Pramanik KK; Mishra R
Exp Cell Res; 2022 Feb; 411(1):112984. PubMed ID: 34951997
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin.
Wang YD; Li SJ; Liao JX
Technol Cancer Res Treat; 2013 Dec; 12(6):525-35. PubMed ID: 23617290
[TBL] [Abstract][Full Text] [Related]
9. The effects of GLUT1 on the survival of head and neck squamous cell carcinoma.
Li S; Yang X; Wang P; Ran X
Cell Physiol Biochem; 2013; 32(3):624-34. PubMed ID: 24022001
[TBL] [Abstract][Full Text] [Related]
10. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
Zhu H; Yun F; Shi X; Wang D
Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
[TBL] [Abstract][Full Text] [Related]
11. Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer.
Sawayama H; Ogata Y; Ishimoto T; Mima K; Hiyoshi Y; Iwatsuki M; Baba Y; Miyamoto Y; Yoshida N; Baba H
Cancer Sci; 2019 May; 110(5):1705-1714. PubMed ID: 30861255
[TBL] [Abstract][Full Text] [Related]
12. Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin-resistance, invasion and stemness acquisition.
Kashyap T; Nath N; Mishra P; Jha A; Nagini S; Mishra R
Head Neck; 2020 Nov; 42(11):3282-3294. PubMed ID: 32710593
[TBL] [Abstract][Full Text] [Related]
13. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
[TBL] [Abstract][Full Text] [Related]
16. Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC.
Ryan SL; Beard S; Barr MP; Umezawa K; Heavey S; Godwin P; Gray SG; Cormican D; Finn SP; Gately KA; Davies AM; Thompson EW; Richard DJ; O'Byrne KJ; Adams MN; Baird AM
Lung Cancer; 2019 Sep; 135():217-227. PubMed ID: 31446998
[TBL] [Abstract][Full Text] [Related]
17. Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis.
Chen X; Yu J; Tian H; Shan Z; Liu W; Pan Z; Ren J
J Cell Physiol; 2019 Nov; 234(11):19130-19140. PubMed ID: 31187488
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-p23154 promotes the invasion-metastasis potential of oral squamous cell carcinoma by regulating Glut1-mediated glycolysis.
Wang Y; Zhang X; Wang Z; Hu Q; Wu J; Li Y; Ren X; Wu T; Tao X; Chen X; Li X; Xia J; Cheng B
Cancer Lett; 2018 Oct; 434():172-183. PubMed ID: 30026052
[TBL] [Abstract][Full Text] [Related]
19. Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
Li H; Fu L; Liu B; Lin X; Dong Q; Wang E
Gene; 2019 Apr; 693():16-24. PubMed ID: 30690182
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]